Zions Bancorporation National Association UT Sells 223,232 Shares of Kenvue Inc. $KVUE

Zions Bancorporation National Association UT lessened its stake in Kenvue Inc. (NYSE:KVUE) by 97.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,970 shares of the company’s stock after selling 223,232 shares during the quarter. Zions Bancorporation National Association UT’s holdings in Kenvue were worth $81,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of KVUE. AlphaCore Capital LLC boosted its stake in Kenvue by 9.9% during the 2nd quarter. AlphaCore Capital LLC now owns 5,287 shares of the company’s stock valued at $111,000 after purchasing an additional 476 shares during the last quarter. Empirical Finance LLC boosted its position in shares of Kenvue by 1.8% during the second quarter. Empirical Finance LLC now owns 28,309 shares of the company’s stock valued at $593,000 after buying an additional 491 shares during the last quarter. J.W. Cole Advisors Inc. increased its holdings in Kenvue by 3.8% in the 2nd quarter. J.W. Cole Advisors Inc. now owns 15,488 shares of the company’s stock worth $324,000 after buying an additional 574 shares in the last quarter. Spire Wealth Management raised its position in Kenvue by 13.5% in the 2nd quarter. Spire Wealth Management now owns 4,863 shares of the company’s stock worth $102,000 after buying an additional 580 shares during the last quarter. Finally, Versor Investments LP lifted its stake in Kenvue by 2.8% during the 3rd quarter. Versor Investments LP now owns 26,016 shares of the company’s stock valued at $422,000 after acquiring an additional 716 shares during the period. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on KVUE shares. Deutsche Bank Aktiengesellschaft set a $18.00 price target on shares of Kenvue in a research note on Friday, October 24th. Johnson Rice reaffirmed a “neutral” rating on shares of Kenvue in a research report on Tuesday, October 28th. Citigroup boosted their target price on shares of Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research note on Wednesday. Barclays raised their price target on Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Monday, November 10th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Four analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Kenvue presently has an average rating of “Hold” and a consensus target price of $20.08.

Kenvue Price Performance

NYSE KVUE opened at $18.87 on Thursday. The business’s fifty day moving average is $17.48 and its 200 day moving average is $17.66. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. The company has a market capitalization of $36.15 billion, a PE ratio of 24.51 and a beta of 0.59.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a return on equity of 19.86% and a net margin of 9.72%.The business had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. During the same quarter in the prior year, the business posted $0.26 earnings per share. The business’s quarterly revenue was up 3.2% on a year-over-year basis. Sell-side analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th will be paid a dividend of $0.2075 per share. The ex-dividend date is Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.4%. Kenvue’s dividend payout ratio (DPR) is presently 110.67%.

Key Headlines Impacting Kenvue

Here are the key news stories impacting Kenvue this week:

• Positive Sentiment: Kenvue reported stronger-than-expected adjusted Q4 results (adjusted EPS $0.27 vs. ~$0.22 consensus) and revenue that beat or matched Street views, with management citing margin gains and broad-based global growth — a near-term earnings beat that supports the stock. Kenvue Tops Q4 Earnings Estimates, Advances Toward Kimberly‑Clark Deal
• Positive Sentiment: The proposed acquisition by Kimberly‑Clark is making visible progress, which investors view as a catalyst for potential strategic and cost synergies; coverage highlights the deal moving forward alongside Kenvue’s results. Kenvue Surges as Earnings Beat, Kimberly‑Clark Merger Gains Steam
• Neutral Sentiment: Kenvue’s official release reiterated stronger top‑ and bottom‑line execution in Q4 and management’s focus on performance as it looks to 2026 — useful context but largely restates the beat and strategic priorities. Kenvue Reports Fourth Quarter and Full Year 2025 Results
• Negative Sentiment: Kenvue announced a global headcount reduction (~3.5% of workforce) and other restructuring steps tied to the Kimberly‑Clark transaction — a move that should lower future costs but may bring one‑time charges and integration/execution risk in the near term. Kenvue to Cut 3.5% of Workforce Ahead of Kimberly‑Clark Deal
• Negative Sentiment: Third‑party reports note GAAP/diluted EPS and operating cash‑flow softness versus some estimates (differences between adjusted vs. GAAP metrics), and data showing significant institutional rebalancing — factors that introduce downside risk if cash generation and accounting metrics continue to lag. Kenvue Inc. (KVUE) Releases Q4 2025 Earnings: Revenue Slightly Beats, EPS Misses

Insiders Place Their Bets

In other news, Director Jeffrey C. Smith purchased 3,200,000 shares of the company’s stock in a transaction on Friday, December 12th. The stock was acquired at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the completion of the transaction, the director directly owned 27,307,632 shares in the company, valued at $474,333,567.84. This trade represents a 13.27% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.68% of the stock is owned by corporate insiders.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.